Abstract
Background: Community iron supplementation programmes for pregnant women have lacked effectiveness, partly because of low compliance. Objective: To determine factors that influence compliance among pregnant women in Senegal. Design: Two hundred and twenty-one pregnant women, recruited from six health centres in Dakar during their first prenatal visit, were randomly assigned to receive either a prescription to purchase iron/folic acid tablets (control, n = 112) to be taken daily, according to official policy, or to receive free tablets (treatment, n = 109). Compliance was assessed 20 weeks after enrolment through interviews and pill count. Women with low or high compliance (<70% or ≥70%) were asked to explain what influenced their adherence to supplementation. Results: Overall compliance was 69%; it was significantly higher in the treatment than in the control group (86% vs. 48%; P < 0.0001). Women with high compliance (58%) were motivated by: (1) the perception of improved health upon taking the tablets (treatment = 24%, control = 10%); (2) the insistence by midwives that they take the tablets; and (3) the mention that the tablets would improve health. Women with low compliance (42%) reported: (1) the experience of side-effects that they associated with the tablets (treatment = 13%, control = 14%); (2) misunderstanding that they needed to continue taking the tablets throughout pregnancy (treatment = 0%, control = 18%); and (3) forgetfulness. Conclusion: Compliance with iron/folic acid supplementation in Senegal can be increased by providing women with clear instructions about tablet intake and educating them on the health benefits of the tablets. © The Authors 2007.
Author supplied keywords
Cite
CITATION STYLE
Seck, B. C., & Jackson, R. T. (2008). Determinants of compliance with iron supplementation among pregnant women in Senegal. Public Health Nutrition, 11(6), 596–605. https://doi.org/10.1017/S1368980007000924
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.